Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexDJIA S&P500 P/E20.55 EPS (ttm)1.83 Insider Own0.10% Shs Outstand5.96B Perf Week1.13%
Market Cap223.57B Forward P/E12.19 EPS next Y3.08 Insider Trans-7.69% Shs Float5.85B Perf Month3.62%
Income11.05B PEG3.17 EPS next Q0.74 Inst Own73.20% Short Float1.01% Perf Quarter3.33%
Sales52.67B P/S4.24 EPS this Y49.80% Inst Trans0.15% Short Ratio2.89 Perf Half Y2.65%
Book/sh11.78 P/B3.19 EPS next Y4.30% ROA12.80% Target Price39.86 Perf Year12.77%
Cash/sh1.92 P/C19.58 EPS next 5Y6.49% ROE33.40% 52W Range32.32 - 39.43 Perf YTD3.62%
Dividend1.36 P/FCF30.92 EPS past 5Y7.90% ROI9.90% 52W High-5.21% Beta0.92
Dividend %3.62% Quick Ratio1.00 Sales past 5Y-0.80% Gross Margin79.20% 52W Low15.64% ATR0.37
Employees90200 Current Ratio1.30 Sales Q/Q1.00% Oper. Margin24.80% RSI (14)66.41 Volatility0.93% 0.96%
OptionableYes Debt/Eq0.58 EPS Q/Q14.80% Profit Margin41.30% Rel Volume0.63 Prev Close37.53
ShortableYes LT Debt/Eq0.45 EarningsJul 31 BMO Payout35.60% Avg Volume20.51M Price37.38
Recom2.50 SMA201.96% SMA503.40% SMA2003.53% Volume1,864,592 Change-0.41%
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jul-16-18 08:31AM  Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population Zacks
07:21AM  With General Electric Gone, Which Dow Component Will Be Kicked Out Next? Motley Fool
Jul-15-18 07:50PM  [$$] This Form of Ambien Now Costs Over 800% More The Wall Street Journal
Jul-14-18 09:00AM  [$$] Drugmaker Raises Price of Sleep Aid Over 800% The Wall Street Journal
Jul-13-18 03:09PM  Novartis Looks to Exit Antibacterial, Antiviral Program Zacks
02:30PM  U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC) PR Newswire
02:30PM  U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC) Business Wire
10:19AM  7 Hot Stocks Savvy Investors Are Buying InvestorPlace
09:47AM  5 Big Pharma Stocks Investors Love Right Now InvestorPlace
08:50AM  Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit Zacks
08:34AM  Dow 30 Stock Roundup: Boeing Q2 Commercial Deliveries Up Y/Y, Pfizer to Reorganize Zacks
12:15AM  [$$] Pfizer boss humbled after man to man talk with Donald Trump Financial Times
Jul-12-18 10:11AM  3 Real Risks That Could Make You Reconsider Buying Celgene Stock InvestorPlace
09:35AM  Pfizer (PFE) to Reorganize Business Into Three New Units Zacks
09:30AM  Is Pfizer (PFE) Outperforming Other Medical Stocks This Year? Zacks
09:08AM  Your first trade for Thursday, July 12 CNBC
08:59AM  3 Gene Therapy Stocks Investors Can Bet on in Rest of 2018 Zacks
08:00AM  Today's Research Reports on Stocks to Watch: Achieve Life Sciences and Pfizer ACCESSWIRE
02:00AM  [$$] The drug pricing playbook: how pharma companies keep costs high Financial Times
12:37AM  [$$] Pfizer to Reorganize Business Units The Wall Street Journal
12:15AM  [$$] Battle erupts between Fox and Comcast for UKs Sky Financial Times
12:00AM  Many Drugmakers Ignore Trumpand Raise Prices Anyway Bloomberg
Jul-11-18 08:00PM  Elliott Tackles AC Milan After Chinese Investors Falter; Pfizer Eyes Reorg-ICYMI TheStreet.com
06:10PM  REPLAY: Jim Cramer on Tariffs, Oil Prices and Pfizer's Reorganization TheStreet.com
05:54PM  Pfizer's China Exposure Could Dampen Its Reshuffle Hopes TheStreet.com
05:07PM  Pfizer separates consumer health unit in business rejig Reuters
04:25PM  Pfizer's Reorganization Into 3 Businesses Seeks to Unlock Value TheStreet.com
04:24PM  Pfizer: Why This Blue-Chip Dividend Stock Is a Buy Today TheStreet.com
04:03PM  Dow Slumps on Trump Trade War Escalation TheStreet.com
04:01PM  4 Things You Need to Know About Pfizer's Restructuring Plans Motley Fool
04:00PM  Dying to Survive, China Shows the Way on Drug Prices Bloomberg
03:56PM  [$$] Investors Should Be Worried About Pfizer's Reversal Barrons.com
03:31PM  Trump told Pfizer CEO price hikes hurt his drug plan: source Reuters
03:11PM  Russian Drugmaker Granted License to Produce Celgene Copycat Fortune
02:41PM  Pfizer to split into three units Reuters Videos
02:01PM  The Midday Rundown: July 11, 2018 CNBC Videos
01:50PM  3 Key Lessons From Trumps Drug Price Feud With Pfizer Fortune
12:35PM  Pfizer Separates Consumer Health Care Unit Benzinga
12:12PM  Pfizer Is Not at a Buy Point, but Here's an Options Play on the Name TheStreet.com
12:10PM  Pfizer Reorganization Could Set the Stage for Full-Blown Spin-off TheStreet.com
12:10PM  Pfizer Reorganization Could Set the Stage for Full-Blown Spinoff TheStreet.com
11:32AM  Trump told Pfizer CEO price hikes hurt his drug plan: source Reuters
11:13AM  Jim Cramer Reacts to Pfizer's Reorganization TheStreet.com
11:03AM  Cramer sees Pfizer's reorganization as a 'prelude' to a spin off of its consumer health-care business CNBC
10:52AM  Pfizer Doesn't Look Fundamentally or Technically Strong TheStreet.com
10:22AM  Trump Said He Got Pfizer to Roll Back Prices. Not Really. Bloomberg
10:15AM  Pfizer Caving to Trump Has Wall Street Worried About Who's Next Bloomberg
09:56AM  Pfizer to Reorganize Itself Into 3 Business Units TheStreet.com
09:51AM  How Companies Navigate Trump's Tweets, Trade Tariffs Bloomberg Video
09:23AM  Stocks to Watch: Boeing, Ford, American Airlines, JetBlue, Pfizer, Comcast, Alphabet, Nvidia, AbbVie The Wall Street Journal
09:07AM  Pfizer to split into three units, separates consumer healthcare Reuters
08:45AM  Pfizer reneged on price increases after drawing ire of Trump American City Business Journals
08:39AM  [$$] Pfizer to postpone price increases after talks with Trump Financial Times
08:35AM  Pfizer reorganizes to handle aging consumers and patents Associated Press
08:31AM  Pfizer to Defer Price Increases After Discussion With Trump Zacks
08:18AM  [$$] Pfizer to Reorganize Business Units The Wall Street Journal
08:02AM  [$$] Pfizer to reorganise into 3 units after failed attempt to sell consumer health Financial Times
07:46AM  Stocks making the biggest moves premarket: FOXA, NFLX, PFE, GOOGL, TSLA & more CNBC
07:44AM  Pfizer Inc to split company into three units Reuters
07:30AM  [$$] Daily briefing: Trump attacks Germany, Facebook fine, Africas richest man Financial Times
07:30AM  China Tariffs, Fox-Sky, Pfizer, Apple, Free Slurpees - 5 Things You Must Know TheStreet.com
07:24AM  Pfizer announces major reorganization plan Fox Business Videos
07:23AM  [$$] Lex letter from London: Drugs, satellites and a riddle Financial Times
07:07AM  Pfizer Rolls Back Drug Price Hike Following Trump Talks TheStreet.com
07:00AM  Pfizer to reorganize into 3 business units, including a new hospital medicines business MarketWatch
06:53AM  Drug giant Pfizer to reorganize into three businesses CNBC
06:45AM  Pfizer to Organize for Future Growth Business Wire
06:22AM  [$$] Drug Supply Chain Feels the Trump Effect The Wall Street Journal
06:18AM  The Pre-Markets Rundown: July 11, 2018 CNBC Videos
06:01AM  If You're Retired, Consider Buying These 3 Stocks Motley Fool
12:42AM  PRESS DIGEST- Wall Street Journal - July 11 Reuters
Jul-10-18 10:48PM  [$$] Pfizer to Roll Back Price Increases After Trump Criticism The Wall Street Journal
10:16PM  [$$] Pfizer delays drug price rises after discussions with Trump Financial Times
09:31PM  Pfizer delays drug price hikes after talking with Trump Reuters
09:20PM  Pfizer delays drug price hikes after talking with Trump Reuters
08:31PM  Drug company's lawsuit could derail Nevada execution Associated Press
08:17PM  Trump says drug maker Pfizer 'rolling back price hikes' Associated Press
08:03PM  Pfizer says delaying drug price hikes after Trump conversation Reuters
07:58PM  Pfizer says delaying drug price hikes after Trump conversation Reuters
07:44PM  Pfizers Announces It Will Defer Companys Price Increases Business Wire
07:42PM  Trump praises Pfizer rolling back prices Fox Business Videos
07:36PM  [$$] Pfizer to Roll Back Price Increases After Trump Criticism The Wall Street Journal
07:17PM  Pfizer says it will postpone price increases after discussions with Trump CNBC
07:16PM  Pfizer stock dips as Trump says Pfizer CEO agreed to drop drug price hikes MarketWatch
07:02PM  Trump says Pfizer is rolling back drug price hikes Reuters
06:50PM  Trump Says Pfizer Is Rolling Back Drug Price Hikes Bloomberg
05:21PM  [$$] Trump's Pfizer Tweet: Why the Market Shrugged Barrons.com
11:54AM  Trump Tweets Threat to Pfizer but Investors Shrug it Off InvestorPlace
09:17AM  This ETF Is Looking Healthy (For Now) Benzinga
08:44AM  Drug Pricing in Focus Again as Trump Tweet Slams Pfizer Zacks
08:37AM  Bullish market outlook despite trade concerns? Fox Business Videos
08:10AM  Today's Research Reports on Stocks to Watch: Benitec Biopharma and Pfizer ACCESSWIRE
07:41AM  Stocks making the biggest moves premarket: PEP, EBAY, PFE, WBA, XRX & more CNBC
07:32AM  3 Big Stock Charts for Tuesday: SBA Communications, Pfizer and Range Resources InvestorPlace
Jul-09-18 10:52PM  [$$] Trump, in Tweet, Criticizes Pfizer Price Increases The Wall Street Journal
07:49PM  Trump slams Pfizer after July 1 drug price hikes Reuters
07:01PM  Jim Cramer: The Strength in Pharma, Health Care and Real Estate Is Transient TheStreet.com
06:08PM  Trump slams Pfizer in tweet over drug prices, but stock still ends day up MarketWatch
05:04PM  Trump Blasts Pfizer for High Drug Prices in Tweet, but Stock Still Rises TheStreet.com
05:02PM  Why CTI BioPharma, PetMed Express, and Pfizer Slumped Today Motley Fool
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brand names. This segment also engages in the research and development, as well as contract manufacturing activities. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company for the development of Eliquis; Astellas Pharma US, Inc. for developing Xtandi; Merck KGaA for the development of Bavencio; and Neofluidics, LLC to develop a microfluidics-based platform. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentJun 06Sale36.4519,000692,58282,886Jun 08 01:11 PM
CORNWELL W DONDirectorJun 04Sale36.405,223190,1170Jun 05 04:44 PM
READ IAN CChairman & CEOMay 01Sale36.01132,3124,764,0811,144,703May 03 04:19 PM
JOHNSON RADY AExecutive Vice PresidentMar 13Sale36.5527,323998,66643,178Mar 14 05:19 PM
LANKLER DOUGLAS MExecutive Vice PresidentMar 13Sale36.8950,0001,844,39883,857Mar 14 05:13 PM
Dolsten MikaelPresident R&DMar 09Sale36.5969,6992,550,39451,185Mar 12 05:01 PM
HILL CHARLES HExecutive Vice PresidentMar 06Sale35.7642,3931,515,98557,328Mar 07 04:09 PM
Dolsten MikaelPresident R&DMar 02Sale35.8513,986501,398120,884Mar 05 09:23 AM
HILL CHARLES HExecutive Vice PresidentFeb 28Option Exercise27.37101,8722,788,237207,942Mar 02 03:24 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37121,1453,315,739362,707Mar 02 04:10 PM
OLSON LAURIE JExecutive Vice PresidentFeb 28Option Exercise27.3738,5461,055,004132,702Mar 02 04:02 PM
READ IAN CChairman & CEOFeb 28Option Exercise27.37649,78017,784,4791,774,184Mar 02 04:03 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.37110,1323,014,313245,362Mar 02 04:03 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50239,801Mar 02 03:44 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50285,910Mar 02 03:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3746,8061,281,080171,276Mar 02 03:44 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 28Option Exercise27.37104,6262,863,614384,219Mar 02 03:44 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37209,2515,727,200655,161Mar 02 03:24 PM
BOURLA ALBERTChief Operating OfficerFeb 28Option Exercise27.3739,9231,092,693184,120Mar 02 03:24 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3733,040904,305136,847Mar 02 03:24 PM
Dolsten MikaelPresident R&DFeb 28Option Exercise27.37198,2385,425,774293,352Mar 02 03:24 PM
HILL CHARLES HExecutive Vice PresidentFeb 28Sale36.8326,779986,292181,163Mar 02 03:24 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Sale37.0333,3681,235,591135,230Feb 28 06:14 PM
Dolsten MikaelPresident R&DFeb 27Sale37.0464,5872,392,31395,114Feb 28 06:04 PM
CORNWELL W DONDirectorFeb 27Sale37.0530011,1150Feb 28 01:29 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 26Sale37.199,510353,67717,770Feb 27 07:38 PM
CORNWELL W DONDirectorFeb 26Sale36.741,45853,5640Feb 28 01:29 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9043,520822,528223,733Feb 27 08:59 PM
READ IAN CChairman & CEOFeb 24Option Exercise19.83903,55917,917,2651,560,007Feb 27 08:58 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9015,716297,03290,222Feb 27 07:53 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456206,972Feb 27 07:51 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9015,885300,22762,848Feb 27 07:43 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9028,288534,643112,081Feb 27 07:43 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456313,499Feb 27 07:43 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 24Option Exercise18.9015,957301,58736,959Feb 27 07:38 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 24Option Exercise18.9039,555747,590143,152Feb 27 07:38 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9065,2801,233,792122,609Feb 27 07:38 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90174,0813,290,131225,265Feb 27 07:32 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9028,288534,643116,769Feb 27 07:30 PM
BOURLA ALBERTChief Operating OfficerFeb 24Option Exercise18.9025,387479,814158,170Feb 27 07:30 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90174,0813,290,131511,470Feb 27 07:30 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 15Sale37.006,750249,750103,458Dec 18 06:17 PM
JOHNSON RADY AExecutive Vice PresidentDec 15Sale37.078,000296,56046,963Dec 18 06:17 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentNov 01Sale34.947,350256,809110,082Nov 02 07:03 PM
PFIZER INC10% OwnerOct 10Buy17.0040,000680,0001,427,639Oct 10 04:22 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentOct 02Sale35.657,350262,028117,432Nov 02 07:03 PM
SUSMAN SALLYExecutive Vice PresidentSep 12Sale35.0038,2301,338,050115,096Sep 14 09:13 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentSep 01Sale34.007,350249,900124,774Sep 05 06:15 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 31Sale34.007,350249,900132,124Sep 01 06:37 PM
DAMELIO FRANK AExecutive Vice PresidentAug 31Sale34.0094,4093,209,906337,389Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.00141,1934,800,56280,762Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.0055,9751,903,150580,318Sep 01 06:37 PM
OLSON LAURIE JExecutive Vice PresidentAug 21Sale32.708,064263,69374,506Aug 23 03:51 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 07Sale33.5015,000502,560139,474Aug 09 05:00 PM
READ IAN CChairman & CEOAug 04Sale34.0068,8342,340,356221,955Aug 08 05:02 PM
READ IAN CChairman & CEOAug 04Sale34.0028,116955,944636,293Aug 08 05:02 PM
open in yahoo | open in reuters | open in google